Emcure Pharmaceuticals Ltd.
EMCURE
Hisse Senetlerindeki Sıralama
#4327
Emcure Pharmaceuticals Limited is committed to providing high-quality,... Emcure Pharmaceuticals Limited is committed to providing high-quality, cost-effective healthcare solutions to a global market. The company boasts a diverse product lineup spanning numerous medical fields, such as women's health (gynecology), anti-infectives, pain relief, nutritional supplements (vitamins, minerals, and nutrients), hematology, oncology, respiratory treatments, HIV antivirals, gastrointestinal remedies, anti-diabetics, neurological medications, and cardiovascular therapies. Notable brand names under their umbrella include Orofer XT, Tenectase, Pause, Metpure XL, Vylda, Vitanova, and Proxym. Founded in 1981, Emcure Pharmaceuticals Limited is headquartered in Pune, India.
Hisse Fiyatı
$18.92
Piyasa Değeri
$3.59B
Değişim (1 gün)
-2.53%
Değişim (1 yıl)
19.64%
Ülke
IN
Ticaret Emcure Pharmaceuticals Ltd. (EMCURE)
Kategori
Healthcare
Emcure Pharmaceuticals Ltd. (EMCURE) için temettü verimi geçmişi
Emcure Pharmaceuticals Ltd. (hisse sembolü: EMCURE) temettü verimi (TTM) 2026 itibariyle: 0
Son 5 yılın ortalama temettü verimi: 0.00%
Son 5 yılın ortalama temettü verimi: 0.00%
Emcure Pharmaceuticals Ltd. (EMCURE) için 2025 - 2026 arası temettü verimi geçmişi
Her yılın sonunda temettü verimi (TTM)
| Yıl | Temettü Verimi | Değiştir |
|---|---|---|
| 2025 | 0.00% | 0.00% |
Benzer şirketler veya rakiplerin temettü verimi (TTM)
| Şirket | Temettü Verimi | Ülke |
|---|---|---|
| 0.00% |
DE
|
|
| 0.00% |
DE
|
|
| 0.00% |
JP
|
|
| 0.00% |
CH
|
|
| 0.91% |
IN
|
